mice a low Ca 2ϩ diet and measured transepithelial Ca 2ϩ transport in everted duodenal sacs incubated in solutions containing glucose, fructose, or their nonmetabolizable analogs. The diet-induced increase in active Ca 2ϩ transport was proportional to dramatic increases in expression of the Ca 2ϩ -selective channel transient receptor potential vanilloid family calcium channel 6 as well as of the Ca 2ϩ -binding protein 9k (CaBP9k) but not that of the voltage-dependent L-type channel Ca(v)1.3. Crypt-villus distribution of CaBP9k seems heterogeneous, but low Ca 2ϩ diets induce expression in more cells. In contrast, KHK distribution is homogeneous, suggesting that fructose metabolism can occur in all enterocytes. Diet-induced Ca 2ϩ transport was not enhanced by addition of the enterocyte fuel glutamine and was always greater in sacs of wild-type, GLUT5
Ϫ/Ϫ , and KHK Ϫ/Ϫ mice incubated with fructose or nonmetabolizable sugars than those incubated with glucose. Thus duodenal Ca 2ϩ transport is not affected by fructose and enterocyte ATP concentrations but instead may decrease with glucose metabolism, as Ca 2ϩ transport remains high with 3-O-methylglucose that is also transported by sodium-glucose cotransporter 1 but cannot be metabolized.
calbindin; fructose; glucose; glucose transporter 5; metabolism; nutrition INTESTINAL CALCIUM TRANSPORT has saturable and nonsaturable components and may be passive and paracellular or active and transcellular (6, 8, 16, 32, 40) . Transepithelial active Ca 2ϩ transport across the enterocyte occurs mainly in the proximal intestine and is thought to consist of three major steps, which are 1) passive Ca 2ϩ entry mainly via the Ca 2ϩ -selective channel, transient receptor potential vanilloid family calcium channel 6 (TRPV6), on the apical membrane, 2) Ca 2ϩ translocation across the cytoplasm with Ca 2ϩ -binding protein D 9 K (CaBP9k, calbindin), and 3) active Ca 2ϩ extrusion from the enterocyte to the blood by the plasma membrane Ca 2ϩ -ATPase isoform 1b (PMCA1b) and the Na ϩ /Ca 2ϩ exchanger isoform 1 (NCX1) (40) . Thus the basolateral exit step requires energy either directly via ATP hydrolysis or indirectly via the Na ϩ gradient. Active transepithelial Ca 2ϩ transport mediated primarily by these transporters is typically very low in adult mammals consuming diets containing normal Ca 2ϩ levels but can be induced mainly in the duodenum by 1,25(OH) 2 D 3 during chronic physiological (e.g., growth, pregnancy, and lactation) and nutritional (e.g., dietary Ca 2ϩ deficiency) Ca 2ϩ stress (6, 8, 16, 32, 40) . This study used low-Ca 2ϩ , vitamin D-sufficient diets to upregulate Ca 2ϩ transporter activity in the duodenum and is thus concerned primarily with acute effects of sugars on diet-inducible, 1,25(OH) 2 D 3 -regulated, active Ca 2ϩ transport.
Because it is important for intracellular signaling and for the regulation of cardiac and muscle activity, Ca 2ϩ concentrations in the blood are tightly regulated within a very narrow range, so acute deficiencies are quickly addressed at the expense of Ca 2ϩ stores in the skeleton, whereas chronic deficiencies are typically resolved by adaptive increases in active Ca 2ϩ transport in the small intestine and kidney. Intestinal Ca 2ϩ absorption may depend, not only on dietary Ca 2ϩ and serum vitamin D concentrations, but also on dietary factors that may alter luminal Ca 2ϩ concentrations or interfere with Ca 2ϩ transporters. Dietary factors that have been shown to affect Ca 2ϩ bioavailability include plant fiber, fat, phosphorus, protein, and carbohydrate (1, 2, 9, 35) . Concerning potential interactions between intestinal carbohydrate and Ca 2ϩ absorption, most investigations have focused on the stimulating effect of the milk sugar lactose on the absorption of Ca 2ϩ (3, 14, 27, 51, 52) , as these two nutrients are typically in the intestinal lumen at the same time. Moreover, monosaccharides such as glucose and/or galactose have also been reported to acutely affect intestinal Ca 2ϩ transport (11, 60, 69, 75) . There have only been a few studies that evaluated the direct effect of fructose on Ca 2ϩ absorption (3, 69) , but these early pioneering studies used high luminal fructose concentrations (550 and 160 mM) and were conducted using sacs of the rat ileum, which expresses few transporters and thus exhibits little active Ca 2ϩ transport (8) . More importantly, none of these studies studied the acute effects of sugars on that component of Ca 2ϩ transport that is diet-inducible and thus important during periods of physiological and nutritional Ca 2ϩ stress. Like diet-inducible active Ca 2ϩ transport, sugar transport also occurs mainly in the proximal intestine (29) . Apical glu-cose and galactose sodium-glucose cotransporter 1 (SGLT1)-mediated transport into the cell is active and electrogenic (72) . Depending primarily on the nutritive status of the body, glucose can be metabolized but is generally accumulated to a high concentration in the cytosol for the facilitative glucose transporter 2 (GLUT2)-mediated downhill transport into the blood containing ϳ5 mM glucose (15, 44) . In contrast, transepithelial fructose absorption is entirely passive. Uptake across the apical membrane is mediated by GLUT5, whereas basolateral exit is mediated by GLUT2 (53, 65) . Fructose is not bound to any protein during transit across the cytosol but can be metabolized in the enterocytes (33, 54) . Compared with glucose metabolism, which is highly regulated, fructose catabolism is irreversibly initiated by the ketohexokinase (KHK, also known as fructokinase) enzyme, which produces fructose-1-phosphate (19, 38) . After fructose uptake, fructose-1-phosphate is rapidly accumulated, whereas creatine phosphate, ATP, or intracellular Pi concentrations are reduced in the enterocyte (33, 38, 45, 49, 54) . The mechanism underlying the depletion of energy-rich intermediates and accumulation of fructose-1-phosphate is thought to be the relatively slow activity of downstream enzymes that further catabolize fructose-1-phosphate, compared with that of KHK (68, 71) .
How can transport between Ca 2ϩ and fructose, or between Ca 2ϩ and glucose, possibly interact, as their intestinal absorption involves completely different apical, intracellular, and basolateral proteins? This question is timely because a growing number of modern dairy products that are used as primary nutritive Ca 2ϩ sources (55) is now sweetened with highfructose corn syrups (HFCS), which usually contain 55% fructose and 45% glucose (36) . Moreover, fructose consumption rates have increased dramatically such that fructose now constitutes ϳ10% of daily energy intake (23), whereas Ca 2ϩ intake by Americans has decreased markedly to levels below recommended (7, 55) . Likewise, glucose constitutes about half of HFCS and, the table sugar sucrose is the end product of luminal starch digestion and can reach average luminal concentrations of ϳ48 mM that may be high enough as to affect Ca 2ϩ transport (31) . We have previously shown fructose concentrations from luminal fluids to average ϳ25 mM (43) . These substantial sugar concentrations increase the importance of identifying mechanisms by which luminal sugars can acutely compromise Ca 2ϩ transport. Because intestinal fructose metabolism can markedly reduce intracellular ATP concentrations, we tested the hypothesis that fructose acutely reduces transcellular active Ca 2ϩ transport in the small intestine and predicted that Ca 2ϩ transport should be normal in GLUT5
Ϫ/Ϫ and KHK Ϫ/Ϫ mice that cannot absorb and metabolize, respectively, dietary fructose.
MATERIALS AND METHODS
Animal and experimental design. Male C57BL/6 wild-type mice weighing 13-15 g (4 wk old) were obtained from Taconic (Germantown, NY) and housed in the Research Animal Facility of the NJMS in a temperature-controlled room of 22-24°C with a 12-h:12-h light/ dark cycle. Mice were fed on a regular laboratory nonpurified diet (Purina Mills, Richmond, IN) and had access to water ad libitum before the beginning of the experiment. Both KHK Ϫ/Ϫ (lacking both ketohexokinase isoforms A and C) and GLUT5 Ϫ/Ϫ mice have the same background strain as wild-type. Generation of KHK Ϫ/Ϫ (19) and GLUT5
Ϫ/Ϫ (73) are as described in detail previously. Intestines from CaBP9k Ϫ/Ϫ mice were a generous gift from Prof. Sylvia Christakos of the New Jersey Medical School. All of the procedures conducted in this study were approved by the Institutional Animal Care and Use Committee of NJMS.
In this study, all mice used for transport studies were chronically fed either a low-or normal-Ca 2ϩ diet, and dietary carbohydrate content was similar in both diets. Thus 4-wk-old wild-type, KHK Ϫ/Ϫ , and GLUT5
Ϫ/Ϫ mice were each divided into two groups and fed either with normal-Ca 2ϩ (0.5% Ca 2ϩ diet; D10122104 based on AIN-93M; Research Diets, New Brunswick, NJ) or low-Ca 2ϩ diet (0.02% Ca 2ϩ ; D11040807) for 4 wk. Our proximate analysis confirmed these Ca 2ϩ levels and also indicated that concentrations of phosphate and other electrolytes were the same in both diets. Active intestinal Ca 2ϩ transport was determined using the everted gut sac assay described below, in the presence of various sugars added in the incubation medium. Tissue was also harvested, and RNA was isolated for quantification of gene expression by real-time PCR.
As we were comparing in some experiments the acute effects of different sugars on diet- When it was shown that upregulation by low-Ca 2ϩ diet was the same in all three genotypes, we studied the acute effects of glucose and fructose on this inducible component of Ca 2ϩ transport. Whenever we were able to wean two same-age KHK Ϫ/Ϫ or GLUT5 Ϫ/Ϫ males, both were fed low-Ca 2ϩ diets, and, after 4 wk, Ca 2ϩ transport was determined in the presence of glucose in one duodenal sac from one mouse and in the presence of fructose in another sac from another mouse.
In vitro intestinal Ca 2ϩ transport. Mice were weighed and anesthetized by an i.p. injection of 2-4 ml/kg body wt of a mixture of ketamine (20 mg/ml) and xylazine (2.5 mg/ml). Intestinal Ca 2ϩ transport was determined using the classical everted gut sac method, following protocols validated using TRPV6/CaBP-null (double deletion) mice by Benn et al. (5) and described in detail by others (6, 8) , who showed that the everted gut sac assay selectively measures active intestinal Ca 2ϩ transport because the Ca 2ϩ transport is against a concentration gradient, occurs at low concentrations of Ca 2ϩ , and is saturable. In fact, many kinetic characteristics of Ca 2ϩ transport determined by the everted sac method are in many respects similar to those of observed in vivo (26, 59) . We also showed that Ca 2ϩ transport in uneverted compared with everted sacs is low and likely paracellular (25) . We used the everted sac as many studies on Ca 2ϩ transport have used this method. Only one everted sac from the duodenum could be taken per animal. We used the duodenum because 1) active, diet-inducible Ca 2ϩ transport decreases markedly in more distal intestinal regions and 2) fructose and glucose absorption are greater in the duodenum and proximal jejunum than in more distal regions (6, 12, 25, 28) .
The first 7 cm of the proximal duodenum was removed, rinsed with ice-cold Ca 2ϩ transport buffer [(in mM) 125 NaCl, 11.3 HEPES, and 0.25 CaCl2, pH ϭ 7.4, osmolality ϭ 280 mOsm/kg], and then slowly everted by rolling the segment along the stainless steel rod. The everted intestinal segment was filled with 500 l of Ca 2ϩ transport buffer with 10 mM glucose, fructose, or sugar analogs that was trapped inside by tying threads on both ends. The sugar concentration of 10 mM was based on our previous findings on average total intestinal luminal glucose and fructose (0.4 -26 mM) concentrations that can reach up to 48 mM in the duodenum during peak feeding times (31, 43) . The sacs were incubated in test tubes with exactly the same incubation buffer as that inside the sac, plus 45 CaCl2 (40,000 cpm/ml). After 1 h, the intact sacs were removed, and 50 l of serosal fluid were collected and then analyzed for 45 Ca 2ϩ in Ecolume (a premixed liquid scintillation cocktail, MP Biomedical, Solon, OH), using a liquid scintillation counter (Beckman LS6500; Beckman, Fullerton, CA). The active accumulation of 45 Ca 2ϩ inside the sac was expressed as a ratio of the final concentration of 45 Ca 2ϩ inside (serosal compartment) and 45 Ca 2ϩ outside (mucosal compartment). After the removal 50 l from the serosal compartment for counting, excess fluid was drained from the sac, and the tissue was blotted dry, weighed, and digested using Solvable (PerkinElmer, Waltham, MA) at 37°C for 24 h before 45 Ca 2ϩ determination. 45 Ca 2ϩ accumulated in the tissue was divided by the weight of the empty sac.
In some studies, the ratio of 45 Cain/ 45 Caout in mice fed a low-Ca 2ϩ diet was expressed relative to those fed normal Ca 2ϩ for experiments done the same day. This was necessary because breeding of KHK Ϫ/Ϫ and GLUT5 Ϫ/Ϫ mice was not predictable, and thus experiments could not be done with wild-type mice. In turn, Ca 2ϩ transport in sacs from mice fed the normal-Ca 2ϩ diet was normalized to average values from multiple experiments (see Fig. 3 ). Once we demonstrated that a low-Ca 2ϩ diet induced Ca 2ϩ transport in intestines from wild-type, CaBP9k
Ϫ/Ϫ , and GLUT5 Ϫ/Ϫ mice, we then used mice fed only low Ca 2ϩ to determine the effect of acute glucose or fructose incubation on the diet-inducible component of Ca 2ϩ transport (see Fig. 6 ). Here, the ratio of 45 Cain/ 45 Caout in intestines incubated with fructose was expressed relative to those incubated with glucose for experiments done the same day. Ca 2ϩ transport in sacs incubated with glucose was normalized to average values from multiple experiments (see Fig. 6 ). Regarding experiments that used only wild-type mice, no normalization was made, and absolute values are presented, as Ca 2ϩ transport was determined in all treatments simultaneously.
ATP measurement in the intestinal mucosa. Intracellular ATP concentration was determined using a rapid bioluminescence ATP assay kit according to the manufacturer's instructions (EnzyLight ATP assay kit; BioAssay Systems, Hayward, CA). With the use of instruments kept ice-cold in the freezer and ice-cold solutions, ϳ20 cm of the proximal small intestine was flushed with ice-cold PBS (pH 7.4). The mucosa was quickly scraped on a glass slide on ice, suspended in ice-cold HEPES-buffered balanced salt solution (in mM, 25 HEPES, 121 NaCl, 5 NaHCO 3, 4.7 KCl, 1.2 MgSO4·7H2O, 1.1 phosphate, and 2 CaCl2, pH 7.4), and mixed by gentle inversions of test tubes encased in ice. A 125-l aliquot was then pipetted and incubated in 125 l of sugar solution (also dissolved in ice-cold HEPES-buffered balanced salt solution) as instructed (final concentration ϭ 5.5 mM) for 5 min at 37°C. Thus the concentrations of the other components were not changed after 1:1 dilution.
After incubation, the entire sample was immediately transferred into 250 l of 0.2 M trichloroacetic acid solution and homogenized by a tissue grinder (IKA Ultra-Turrax T25 Basic Homogenizer; IKA Works, Wilmington, NC) on ice. The supernatant was separated by centrifugation at 12,000 g for 5 min at 4°C. Two 50-l aliquots of samples were kept in Ϫ80°C until further analyses for protein levels. To measure the ATP level, the supernatant was first buffered with 25 l of 0.2 M NaOH solution, and then 10 l of sample was transferred in duplicate into 96-well white opaque plates (PerkinElmer Life Sciences). Each well contained 90 l of a reconstituting reagent containing a mixture of assay buffer, D-luciferin, and luciferase enzyme at a ratio of 95:1:1 (vol/vol/vol). Luminescence was read against blanks (buffer without sample) using an automated microplate reader (Multilabel HTS Counter; VICTOR, Wallac, Finland) (67) . Protein levels were quantified by BCA protein assay kit (Pierce ThermoFisher Scientific, Rockford, IL), using bovine serum albumin as a protein standard. ATP concentration was normalized to per milligram of protein.
Total mRNA extraction, DNase treatment, and RT reaction. Total RNA was extracted using a commercially available TRIZOL reagent (Invitrogen, Carlsbad, CA). To hydrolyze contaminating DNA in RNA preparation, 100 g RNA was combined with 10 l DNase I and 70 l RDD buffer (RNeasy Mini Kit; Qiagen, Valencia, CA) in a final volume of 100 l. The cDNA was generated from 5 g DNase-treated RNA using 200 U of SuperScript III RNase H Reverse Transcriptase and oligo (dT) 20 (Invitrogen) in a total volume of 20 l.
Gene expression by real-time PCR. Real-time PCR was performed using Mx3000P (Stratagene Real-Time PCR System, La Jolla, CA), as described previously (21) . Primers were designed using Roche primer design software (http://www.roche-applied-science.com) and were purchased from Integrated DNA Technologies (IDT, Coralville, IA) ( Table 1 ). The relative ratio of expression levels of target genes was calculated as described previously (63) . Gene expression was relative to elongation factor-1␣ gene, whose expression was previously found to be independent of Ca 2ϩ level in the diet and of age of the mice. Immunohistochemistry. Two centimeters of mouse duodenum were excised and immediately fixed in fresh 10% paraformaldehyde in PBS (pH ϭ 7.35) overnight at room temperature (25°C). After fixation, tissue samples were embedded in paraffin, then sectioned (ϳ5 m), deparaffinized, and rehydrated as previously described (22) . Antigen unmasking was processed in 10 mM sodium citrate buffer (pH 6.0) solution in heat-induced antigen retrieval programmed pressure cooker (2100-Retriever; ProteoGenix, Schiltigheim, France Ϫ/Ϫ mice, respectively. Statistical analyses. Data are presented as means Ϯ SE. A two-way ANOVA analyzed the effects of genotype and diet or of genotype and incubation solution. When a two-way ANOVA could not be used, a one-way ANOVA was utilized to determine the difference among groups with different treatments. If there was a significant difference, Fisher's paired least significant difference test was used (STATVIEW; Abacus Concepts, Piscataway, NJ) to determine differences among means. Differences were considered significant at P Ͻ 0.05. Graphs were plotted by GraphPad Prism 5.0 (GraphPad Software, San Diego, CA).
RESULTS

Fructose decreases intracellular ATP concentration in wildtype but not in KHK
Ϫ/Ϫ mice. In preliminary work, we determined ATP concentrations in mucosal homogenates incubated in fructose and glucose for up to 20 min (not shown) and found that the rate of ATP reduction was linear for Յ5 min, a time course used in the next series of experiments. Initial ATP concentrations were 47.1 Ϯ 1.4 nmol/mg of protein and did not differ significantly among glucose-and fructose-incubated mucosal homogenates from wild-type and KHK Ϫ/Ϫ mice. After incubation of mucosal homogenates with glucose or fructose solutions, ATP concentrations decreased from initial at a rate of ϳ14%/min in glucose-incubated mucosal homogenates of wild-type mice (Fig. 1A) . Fructose incubation further reduced ATP levels, so the concentration remaining was only 7.9 Ϯ 0.32% of initial or about half of that remaining in glucoseincubated mucosa. By two-way ANOVA, the effects of KHK deletion and of sugar incubation on ATP levels were highly significant (P ϭ 0.005 and 0.02, respectively). The interaction between genotype and sugar treatments was also significant (P ϭ 0.0316), suggesting that fructose-induced ATP reduction depended on genotype. The difference between glucose and fructose effects on ATP concentrations in wild-type mice was highly significant (P Ͻ 0.001). In contrast, in KHK Ϫ/Ϫ mice, the amount of ATP left was similar between fructose-and glucose-incubated mucosa. Increasing the incubation time further reduced ATP levels, but the fructose-incubated mucosa from wild-type mice still had the greatest decrease (Fig. 1B) . By two-way ANOVA, the effects of KHK deletion and of fructose incubation on ATP levels were still significant at 9 min (P ϭ 0.003 and 0.05, respectively). The interaction between genotype and sugar solution was not significant (P ϭ 0.10) although a post hoc t-test between glucose and fructose effects in wild-type mice was highly significant (P Ͻ 0.01). Although this finding merely confirms earlier work indicating marked reductions in enterocyte ATP levels with fructose (33, 38, 48, 54) , it does show for the first time that KHK may be the major reason for this marked decrease in ATP levels in intestinal mucosa exposed to fructose.
CaBP9k and KHK are expressed in the small intestine. We have previously shown GLUT5 protein (25) and mRNA (42) to be expressed in enterocytes lining the villi, especially near the tip. Before testing our hypothesis, we wanted to demonstrate that CaBP9k is found in cells where KHK-mediated fructose metabolism occurs. KHK is clearly found in enterocytes along Ϫ/Ϫ mice fed commercial chow were scraped then placed on glass slides on ice, homogenized in ice, and then incubated in glucose or fructose solutions for 5 and 9 min at 37°C following kit manufacturer instructions. Intracellular ATP concentrations were determined by a rapid bioluminescent method. Values are means Ϯ SE (n ϭ 3-4). Different letters denote significant (P Ͻ 0.05) differences. KHK-mediated fructose metabolism reduces ATP concentrations in intestinal mucosal homogenates.
the villus axis of the duodenum ( Fig. 2A) as well as that of the ileum (Fig. 2B) . The KHK antibody is specific, as indicated by the absence of immunofluorescence in wild-type mice probed with secondary antibody alone, and in KHK Ϫ/Ϫ mice probed with both primary and secondary antibodies (Fig. 2E) . CaBP9k distribution is similar to that of KHK in wild-type mice fed low-Ca 2ϩ diets (Fig. 2A) . However, in wild-type mice fed a normal-Ca 2ϩ diet (Fig. 2C) , there was a marked reduction in CaBP9k immunofluorescence, and CaBP9k was expressed in only a few cells (see merged panel). In mice fed low Ca 2ϩ , there seems to be a regional gradient of CaBP9k expression as levels decrease in the ileum (compare Fig. 2A, left with Fig. 2B,  left) .
CaBP9k distribution was also heterogeneous and seemingly punctuate, with some cells expressing more immunoreactive protein than others, along the intestinal villus axis of GLUT5 Ϫ/Ϫ (not shown) and KHK Ϫ/Ϫ mice (Fig. 2F, left) as well as of rats (Fig.  2F, right) fed normal-Ca 2ϩ diets. The CaBP9k antibody has also been shown to be highly specific as indicated by negative controls of intestinal sections from wild-type (probed with secondary antibody only) and CaBP9
Ϫ/Ϫ (probed with both primary and secondary antibodies) mice (Fig. 2D) .
Low (Fig. 3A) . The amounts of 45 Ca 2ϩ accumulated in tissues were 39.9 Ϯ 3.2 for wild-type, 38.0 Ϯ 2.8 for GLUT5
Ϫ/Ϫ , and 43.8 Ϯ 2.4 ϫ 10 3 cpm/g tissue for KHK Ϫ/Ϫ mice (Fig. 3B) . Because experiments could not be conducted at the same time across genotype, Ca 2ϩ transport in sacs from mice fed low Ca 2ϩ were subsequently normalized to those in sacs from mice fed normal Ca 2ϩ levels for each genotype. When analyzed by two-way ANOVA, genotype had no effect on normalized transepithelial (P ϭ 0.17) and transmembrane (P ϭ 0.62) Ca 2ϩ transport. In contrast, diet had a dramatic effect (P Ͻ 0.0001 for Fig. 3, A and  B) , but there was no interaction between genotype and diet (P Ն 0.28).
The increases in Ca 2ϩ transport were paralleled by dramatic 30-to 40-fold increases in mRNA expression of known major players of Ca 2ϩ transport (40) . Relative TRPV6 and CaBP9k mRNA expression were significantly upregulated by diet (P Ͻ 0.0001 by two-way ANOVA) in intestines of wild-type, , and KHK Ϫ/Ϫ mice fed low-Ca 2ϩ diets (Fig. 4, A  and B) . Protein levels of CaBP9k also seem to increase in wild-type mice fed low Ca 2ϩ (compare Fig. 2 , A and C). Genotype had no significant effect (P Ն 0.06) on TRPV6 as well as CaBP9k expression, and there was no interaction between diet and genotype (P Ն 0.09). PMCA1b expression was independent of dietary Ca 2ϩ in wild-type mice, but, surprisingly, PMCA1b mRNA level increased slightly (ϳ1.7-fold) with low Ca 2ϩ in GLUT5 Ϫ/Ϫ and KHK Ϫ/Ϫ groups (Fig.  4C) . The effects of diet (P Ͻ 0.001) and genotype (P ϭ 0.02) were significant, but there was no interaction (P ϭ 0.53). The only Ca 2ϩ transporter whose intestinal expression did not change with diet (P ϭ 0.80) in any mouse model (P ϭ 0.12) was NCX1 (Fig. 4D) , and there was no interaction between these two factors (P ϭ 0.19). Dietary Ca 2ϩ had no effect on intestinal expression of GLUT5, GLUT2, and KHK involved in fructose transport and metabolism and of SGLT1 involved in active glucose transport (Fig. 4 , E-H) (by two-way ANOVA, P Ն 0.26), and there was also no interaction between dietary Ca 2ϩ and genotype (P Ն 0.48). Because GLUT5 Ϫ/Ϫ mice did not express GLUT5 mRNA, and KHK Ϫ/Ϫ mice did not have KHK mRNA, the effect of genotype was highly significant (P Ͻ 0.0001) on GLUT5 and KHK expression (Fig. 4, E and G) but was insignificant on GLUT2 and SGLT1 expression (P Ͼ 0.30) (Fig. 4, F and H) .
The L-type Ca 2ϩ channel Ca(v)1.3 has been proposed to mediate active intestinal Ca 2ϩ transport in combination with TRPV6 (20, 46) , particularly because active Ca 2ϩ transport is normal in TRPV6 Ϫ/Ϫ mice (5). However, expression of Ca(v)1.3 in enterocytes is ϳ20-to 30-fold less than TRPV6 (data not shown), and Ca(v)1.3 levels did not significantly respond to a low-Ca 2ϩ diet (Fig. 4I ) (P Ͼ 0.10 by two-way ANOVA) although there seemed to be a decrease in Ca(v)1.3 expression in GLUT5
Ϫ/Ϫ mice. There was a significant effect of genotype (P ϭ 0.003), but there was no interaction between dietary Ca 2ϩ and genotype (P ϭ 0.06). The low expression levels contributed to the large variation in estimates of Ca(v)1.3 mRNA expression. It is not clear why Ca(v)1.3 expression decreased in GLUT5 Ϫ/Ϫ mice although this could be a random observation expected to occur 1 out of 20 times at P Ͻ 0.05. Nonetheless, in wild-type, GLUT5
Ϫ/Ϫ , and KHK Ϫ/Ϫ mice, the significant diet-induced increase in Ca 2ϩ transport is clearly paralleled by large diet-induced increases in TRPV6 and CaBP9K, but not in Ca(v)1.3, mRNA expression.
Acute fructose effects on active Ca 2ϩ transport. To test the hypothesis whether fructose decreases active Ca 2ϩ transport, transepithelial Ca 2ϩ transport was determined in everted intestinal sacs from wild-type mice incubated in solutions containing 10 mM glucose (control) or fructose. There were significant treatment effects (P Ͻ 0.001 by one-way ANOVA) on transepithelial (Fig. 5A) and transmembrane (Fig. 5B ) Ca 2ϩ transport. Transepithelial Ca 2ϩ transport was low and similar between glucose-and fructose-incubated sacs obtained from mice fed a normal-Ca 2ϩ diet: 0.35 Ϯ 0.02 and 0.36 Ϯ 0.03, respectively. Ca 2ϩ transport increased markedly (P Ͻ 0.01) in all mice fed low-Ca 2ϩ diets, regardless of incubation solution. This diet-inducible Ca 2ϩ transport was much greater (P Ͻ 0.01) in sacs incubated with fructose compared with those with glucose (1.45 Ϯ 0.21 and 0.93 Ϯ 0.08, respectively). Thus the acute effect of fructose on Ca 2ϩ transport depended on whether sacs came from mice fed normal-or low-Ca 2ϩ diets. L-glutamine at 1-12.8 mM is often used as respiratory fuel to maintain enterocyte cultures (17, 56, 58, 74) . Because fructose was expected to reduce ATP levels in intestinal cells and inhibit diet-induced Ca 2ϩ transport, we predicted that addition of L-glutamine to the incubation media containing fructose would reverse the fructose effects. Glutamine was not added to sacs from mice fed normal Ca 2ϩ , as transepithelial Ca 2ϩ transport there was low, and the acute addition of fructose had similar effects as glucose (control). Glucose-and glucoseϩglutamine-incubated sacs from mice fed low Ca 2ϩ showed similar (P Ͼ 0.5) rates of active Ca 2ϩ transport, which were both greater than those in sacs from mice fed normal Ca 2ϩ . Likewise, Ca 2ϩ fluxes were also similar between sacs incubated with fructose alone and Fig. 3 . Increased rates of Ca 2ϩ transport after consumption of a low-Ca 2ϩ diet for 4 wk. Mice were randomly divided into 2 groups then fed with normal-(NCa) or low-Ca 2ϩ (LCa) diets. Because production of transgenic mice is unpredictable, 0.25 mM Ca 2ϩ transport had to be determined at different times for wild-type, glucose transporter 5 (GLUT5) Ϫ/Ϫ , and KHK Ϫ/Ϫ mice. Thus uptake in low Ca 2ϩ was normalized to that of normal Ca 2ϩ for each genotype. The composition of the solution outside the everted sac is exactly the same as that inside except tracer 45 Ca 2ϩ was added to luminal side (outside the everted sac). All sacs were incubated with 10 mM fructose. A: relative ratios of tracer concentration inside/outside the sacs were clearly much greater in wild-type, GLUT5
Ϫ/Ϫ , and KHK Ϫ/Ϫ mice fed low Ca 2ϩ . B: steady-state tissue 45 Ca 2ϩ accumulation was also much greater in all mice fed low Ca 2ϩ . Bars are means Ϯ SE; **P Ͻ 0.01; *P Ͻ 0.05, n ϭ 5-6. those with fructoseϩglutamine (Fig. 5A) . The pattern of changes in steady-state accumulation of Ca 2ϩ in the mucosal tissue (Fig. 5B ) was similar to that of active transepithelial Ca 2ϩ transport. In both cases, incubation of fructoseor fructoseϩglutamine-incubated sacs from mice fed low Ca 2ϩ still resulted in Ca 2ϩ transport (or accumulation) greater than that in glucose alone-or in glucoseϩglutamine-incubated sacs. Thus addition of glutamine had no additional effect on diet-induced Ca 2ϩ transport.
Deletion of KHK and GLUT5 did not affect diet-induced Ca
2ϩ transport. Ca 2ϩ uptake in the presence of fructose or glucose was determined only in mice fed low Ca 2ϩ , as Fig. 3 showed all three genotypes to adaptively increase Ca 2ϩ transport in response to Ca 2ϩ deficiency. Because the uptake experiment could not be conducted at the same time, uptake rates in fructose-incubated sacs had to be normalized to those of glucose-incubated sacs for each mouse model (Fig. 6, A and B) . The ratios of 45 Ca in / 45 Ca out in glucose-incubated sacs used for exchanger isoform 1 (NCX1) (D), GLUT5 (E), GLUT2 (F), KHK (G), and sodium-glucose cotransporter 1 (SGLT1) (H, control) was examined by real-time PCR. Because recent work suggested it may also play a role in Ca 2ϩ transport, expression of the L-type calcium channel Ca(v)1.3 was also determined (I). NCa and LCa represent normal-and low-Ca 2ϩ diets, respectively. Bars are means Ϯ SE (n ϭ 5-6). *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001 compared with NCa in the same genotype. In contrast to TRPV6 and CaBP9k mRNA expression, which increases by orders of magnitude when a Ca 2ϩ -deficient diet is consumed, Ca(v)1.3 expression does not vary with levels of dietary Ca 2ϩ and with genotype, except in GLUT5 Ϫ/Ϫ mice fed low Ca 2ϩ when Ca(v)1.3 expression decreased markedly. Moreover, relative mRNA abundance of Ca(v)1.3 channels is ϳ20 to 30-fold less compared with that of TRPV6, and the low expression contributed to the unusually large standard error. Bars are means Ϯ SE; n ϭ 5-6. normalization were 0.58 Ϯ 0.02 for wild-type, 0.52 Ϯ 0.05 for GLUT5 Ϫ/Ϫ , and 0.43 Ϯ 0.02 for KHK Ϫ/Ϫ for Fig. 6A . The amounts of 45 Ca 2ϩ accumulated in tissues incubated with glucose were 60.1 Ϯ 2.5 for wild-type, 55.9 Ϯ 1.6 for GLUT5
Ϫ/Ϫ , and 53.1 Ϯ 11.4 ϫ 10 3 cpm/g tissue for KHK
Ϫ/Ϫ
for Fig. 6B . By two-way ANOVA, there was a highly significant effect of incubation solution on transepithelial (P ϭ 0.001) and transmembrane (P ϭ 0.0002) Ca 2ϩ transport. In both measures of Ca 2ϩ transport, genotype had no effect (P Ն 0.18), and there was no interaction between incubation solution and genotype (P Ն 0.70).
Consistent with data from Fig. 5 , diet-induced active Ca 2ϩ transport was greater in fructose-compared with that in glucose-incubated sacs in wild-type mice. In KHK Ϫ/Ϫ mice, diet-induced Ca 2ϩ transport was also greater in fructose-compared with glucose-incubated sacs. Interestingly, in GLUT5
Ϫ/Ϫ mouse intestines that cannot absorb fructose (4) (C. Patel and R. Ferraris, unpublished observations), diet-induced active Ca 2ϩ transport was still greater in fructose-incubated sacs. This finding suggests that fructose likely did not affect diet-induced Ca 2ϩ transport because Ca 2ϩ transport in the presence of fructose was similar among wild-type mice able to absorb and metabolize fructose, KHK Ϫ/Ϫ mice unable to metabolize fructose (41) , and GLUT5 Ϫ/Ϫ mice unable to absorb fructose. The Fig. 6 . The contributions of GLUT5 and KHK on sugar-modulated changes in active intestinal Ca 2ϩ transepithelial transport (A) and Ca 2ϩ tissue uptake (B). Wild-type, KHK Ϫ/Ϫ , and GLUT5 Ϫ/Ϫ mice were fed with low-Ca 2ϩ diet (LCa), killed after 4 wk, and then Ca 2ϩ fluxes were determined in everted sacs containing either 10 mM glucose (G) or fructose (F). Because breeding of transgenic mice is unpredictable, Ca 2ϩ transport was determined at different times for wild-type (WT), GLUT5
Ϫ/Ϫ , and KHK Ϫ/Ϫ mice, and then Ca 2ϩ uptake in fructose-incubated sacs was normalized to that in glucose-incubated, for each genotype. The composition of the solution outside the sac is exactly the same as that inside except tracer 45 Ca 2ϩ was added to luminal side. Bars represent means Ϯ SE (n ϭ 5-6). *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001 compared with glucose-incubated sacs obtained from the same genotype. In all mice, Ca 2ϩ transport was greater in sacs from fructose-fed individuals, even in GLUT5 Ϫ/Ϫ mice, which do not absorb fructose, suggesting that perhaps the difference in Ca 2ϩ transport consistently observed between glucose-and fructose-incubated sacs is due to a glucose-induced reduction of Ca 2ϩ transport. . The everted sacs were incubated in 10 mM glucose (G) or fructose (F) solution and were obtained from wild-type mice fed normal-(NCa) or low-Ca 2ϩ (LCa) diets for 4 wk. L-glutamine (Q, 10 mM) was added as enterocyte fuel in sacs obtained from mice fed low Ca 2ϩ . The composition of the solution outside the sac is exactly the same as that inside except tracer 45 Ca 2ϩ was added to luminal side (outside the everted sac). Error bars represent means Ϯ SE (n ϭ 4). Different letters denote significant (P Ͻ 0.05) differences.
substantial difference between diet-induced Ca 2ϩ transport in the presence of fructose and that in glucose probably could result from a decrease of diet-induced active Ca 2ϩ transport caused by glucose. If this prediction is correct, diet-induced Ca 2ϩ transport in fructose-incubated sacs of wild-type mice should be similar to that of sacs incubated with nonabsorbed sugars like mannitol, and both should be greater than Ca 2ϩ transport in glucose-incubated sacs.
Diet-induced Ca 2ϩ transport may be acutely inhibited by glucose metabolism. In this experiment using wild-type mice, the role of metabolism was further evaluated by determining Ca 2ϩ transport in the presence of the poorly metabolizable GLUT5 substrate 2-deoxy-D-glucose and the nonmetabolized SGLT1 substrate, 3-O-methylglucose, as well as the nonabsorbable sugar mannitol, which represented an osmotic control (10, 18) . 2-Deoxy-D-glucose can be metabolized by hexokinase but not by other glycolytic enzymes, whereas 3-O-methylglucose cannot be metabolized at all.
In wild-type mice fed normal-Ca 2ϩ diet, the Ca 2ϩ fluxes were modest but similar (P Ͼ 0.5) in sacs incubated with glucose and fructose solutions. Active Ca 2ϩ transport was induced (P Ͻ 0.001 by one-way ANOVA) in five groups of mice fed low-Ca 2ϩ diets. Diet-induced Ca 2ϩ transport was always less (P Ͻ 0.01) when sacs were incubated with glucose compared with that of sacs with fructose (Fig. 7, A and B) . 
DISCUSSION
The main findings in this study are that 1) fructose transport, fructose metabolism, and fructose-induced changes in the level of mucosal ATP have no acute effect on active, membrane that involves, not only GLUT5, but also GLUT2 as well (47), we and others (4) found that GLUT5 Ϫ/Ϫ mice cannot absorb fructose and would die if given dietary fructose, suggesting an absence or ineffective distribution of GLUT2 in the apical membrane and that GLUT5 is clearly the main transporter mediating fructose transport from the intestinal lumen. Fructose transport occurs mainly in the proximal regions of rat and mouse intestines (13, 61) , paralleling the regional distribution of GLUT5 (22) and KHK expression, which is modestly reduced in the distal intestine. Many studies have already shown ATP concentrations to decrease markedly in enterocytes and hepatocytes exposed to fructose (33, 38, 45, 49, 54) . Here we show that this well-known fructose-induced decrease in concentrations of high-energy intermediates like ATP may be highly dependent on the metabolism of fructose by KHK.
TRPV6 expression resembles that of CaBP9k and is greatest in the duodenum and corresponds to the location of the vitamin D receptor that regulates intestinal Ca 2ϩ transport (57) . We previously showed that active, diet-inducible Ca 2ϩ transport parallels this marked proximal to distal gradient in Ca 2ϩ transporter expression (21, 25 transport clearly is not affected by fructose metabolism and acute fructose-induced reductions in ATP concentrations because 1) transcellular Ca 2ϩ transport remains unchanged with or without supplementation with glutamine, a major source of respiratory fuel and metabolic energy for intestinal cells (17, 58, 74) , and 2) Ca 2ϩ transport is greater in fructose-compared with glucose-incubated sacs from KHK Ϫ/Ϫ and GLUT5
Earlier studies directly comparing acute effects of glucose and fructose on Ca 2ϩ transport in everted ileal sacs of rats seem to support our findings. Although these rats were likely fed normal-Ca 2ϩ diets and high Ca 2ϩ concentrations were used during incubation, transport of 45 mM Ca 2ϩ was greater in 550 mM fructose than that in glucose (69) . Uptake of 0.1 mM Ca 2ϩ , a low concentration that favors active transcellular uptake, in 160 mM fructose was greater than that in glucose (3). Total intestinal Ca 2ϩ absorption in vivo, determined acutely by femur uptake of 45 Ca 2ϩ , increased proportionally with increasing concentrations of honey, which is composed mostly of fructose (2) .
Acute interactions of diet-induced Ca 2ϩ transport with luminal glucose. Because SGLT1 Ϫ/Ϫ mice develop glucosegalactose malabsorption syndrome (34), a condition also observed in humans with defects in SGLT1 (72), SGLT1 must be primarily responsible for glucose and galactose uptake into the intestinal cells. Glucose enters the cell via SGLT1, depolarizing the membrane, and can be metabolized in the enterocyte cytosol, which contains all enzymes involved in glycolysis (62) . Glucose metabolism is dependent on luminal glucose concentrations as well as satiety state (15, 44) . Because SGLT1 is expressed mainly in the enterocytes lining the villi of the proximal regions of mouse and rat intestines (30) already shown to express CaBP9k, transcellular glucose and CaBP9k-mediated Ca 2ϩ transport can interact. The inhibitory effect of glucose on diet-induced increases in Ca 2ϩ transport is not due to glucose-induced changes in membrane potential reducing the downhill electrical gradient for Ca 2ϩ because Ca 2ϩ transport remains high in sacs incubated in 10 mM 3-O-methylglucose also transported by SGLT1 and thus also depolarizes the membrane (72) . It is possible that glucose and 3-O-methylglucose have different absorption characteristics via SGLT1 and the difference in the effect on Ca 2ϩ transport between the glucose-and 3-O-methylglucose-incubated sacs may not be solely due to the nonmetabolizable nature of 3-O-methylglucose but also to this difference in absorption kinetics. However, the effect of 3-O-methylglucose on Ca 2ϩ transport is similar to those of mannitol and of 2-deoxy-D-glucose, suggesting that the different effect on Ca 2ϩ transport between 3-O-methylglucose and glucose is less likely due to differences in absorption properties but more likely due to differences in metabolic attributes. This conclusion can be confirmed in future work in mouse models without ratelimiting glycolytic enzymes (e.g., hexokinase) and transporters (e.g., SGLT1) in the small intestine.
CaBP9k and KHK distribution along intestinal villus axis. An unexpected finding in this study is the consistently heterogeneous, seemingly punctuate, distribution of CaBP9k in the intestinal mucosa of mice and rats fed normal Ca 2ϩ . The study of Lee et al. (50) and Taylor and Wasserman (64) had similar findings, but the latter ascribed the immunoreactivity to goblet cells. The heterogeneous crypt-villus distribution of CaBP9k that decreases sharply in distal intestinal regions contrasts with that of KHK, which is more homogeneous and still modestly expressed distally. Other studies found CaBP9k-immunoreactive sites to be homogeneously distributed in the villi of rabbit (39) , chick (66) , and human (37) intestines, so perhaps our findings are limited to mice and rats fed sufficient levels of dietary Ca 2ϩ . Feeding with low-Ca 2ϩ diets seems to increase the number of CaBP9k-containing cells as well as the expression of CaBP9k protein in many cells. This is understandable because CaBP9k expression is regulated by vitamin D (8), whose levels increase with Ca 2ϩ deficiency, and the vitamin D receptor appears to be homogeneously expressed in all cells lining the intestinal villi (57, 70) . The heterogeneous CaBP9k distribution along the villus suggests that, in Ca-sufficient rodents, CaBP9k is not significantly expressed in some enterocytes that may have the vitamin D receptor. Future work should confirm and evaluate the graded CaBP9k response of the rodent intestine to Ca 2ϩ sufficiency. Chronic vs. acute effects of sugars on intestinal Ca 2ϩ transport. We previously showed that, in rats and mice with high Ca 2ϩ requirements (e.g., during lactation) or that are nutritionally deficient in Ca 2ϩ , compensatory increases in 1,25-(OH) 2 D 3 -regulated intestinal Ca 2ϩ absorption is strongly inhibited by chronic consumption of dietary fructose (21, 24, 25) . The mechanism underlying this chronic fructose effect is a fructose-induced decrease in levels of 1␣-hydroxylase, the enzyme synthesizing 1,25-(OH) 2 
